Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-019521

EVP, Research & CSO sold 5,560 shares at $44.80 ($249,086)

  • EVP, Research & CSO acquired 5,560 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-09 Exercise or conversion : show line 1 in the form +5,560 $1.53 $8,507 79,760 D
2021-03-09 Sale : show line 2 in the form −5,560 $44.80 $249,086 74,200 D
Open-market sales · 5,560 sh · avg $44.80 · $249,086

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-09 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −5,560 347,795 D
Loading xslF345X03/doc4.xml…